Cimpuciclib tosylate |
| Catalog No.GC65878 |
Cimpuciclib tosylate is a selective CDK4 inhibitor (IC50: 0.49 nM) that has anti-tumor activity.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2408872-84-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Cimpuciclib tosylate is a selective CDK4 inhibitor (IC50: 0.49 nM) that has anti-tumor activity[1].
Cimpuciclib (example 63, 141.2 nM, 6 days) tosylate inhibits proliferation of colo205 cells[1].
Cell Proliferation Assay[1]
| Cell Line: | Colo205 cells |
| Concentration: | 0-500 nM approximately |
| Incubation Time: | 6 days |
| Result: | Inhibited cell proliferation with an IC50 value of 141.2 nM. |
Cimpuciclib (example 63, 50 mg/kg, oral gavage, twice a week) tosylate inhibits tumor growth in colo205 tumor-bearing mice[1].
Cimpuciclib (5 mg/kg for rats, 50 mg/kg for colo205 tumor-bearing mice, oral administration) tosylate shows slow metabolic rate and maintains high concentration in the plasma[1].
| Animal Model: | Colo205 tumor-bearing mice[1] |
| Dosage: | 50 mg/kg, twice a week |
| Administration: | Oral gavage |
| Result: | Inhibited tumor growth by 93.63% |
| Animal Model: | Rats, colo205 tumor-bearing mice[1] | |||||||||||||||
| Dosage: | 5 mg/kg for rats, 50 mg/kg for colo205 tumor-bearing mice. | |||||||||||||||
| Administration: | Oral administration | |||||||||||||||
| Result: | Pharmacokinetic profile of Cimpuciclib (example 63).
|
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *